Skip to main content
. 2019 Sep 5;18(5):3291–3298. doi: 10.3892/etm.2019.7973

Figure 3.

Figure 3.

Prognostic value of METTL7B for relapse-free survival of EAC patients. EAC patients were divided into low and high expression groups according to the median expression level. EAC, esophageal adenocarcinoma; METTL7B, methyltransferase like 7B.